CCR7 and neoplasm: Based on this, research also deemed that PGE2 can upregulate CCR7 at least partly, via inhibiting the activation of LXRα in monocyte-derived DCs (moDCs), so as to promote the infiltration of DCs in the tumor site and avoid tumor immune escape (Youlin et al., 2018).